Stable proteins – Delivered.
Unlock the Future of Therapeutic Stability
DyoGel, a research project at the University of Glasgow, is eliminating the need for cold chain logistics. Our hydrogel-based technology protects protein-based therapeutics from thermal and mechanical stress – maintaining stability and efficacy without refrigeration or lyophilisation.
How Does It Work?
Revolutionising Protein Therapeutics with Next-Generation Hydrogel Stabilisation
Cold chain dependence is costly, energy-intensive, and limits access to life-saving treatments.
DyoGel’s platform offers a smarter, more sustainable solution that keeps your proteins stable from production to patient.
With DyoGel, you can:
Cut costs by up to 73% from storage, distribution, and waste.
Extend market exclusivity through bespoke, patentable formulations.
Who We Work With
Our technology is designed for forward-thinking organisations ready to lead the next era of sustainable biopharmaceutical development:
Healthcare NGOs and global health initiatives
committed to funding new technologies to increase patient access and reduce environmental impact.
BioPharma decision-makers
seeking reliable, cost-efficient stabilisation solutions for their protein-based therapeutics.
Have Your Say!
We’d love your feedback. Take our short survey and help us shape the future of our work.
Partner With Us
Interested in exploring how DyoGel’s stabilisation platform can transform your therapeutic pipeline or sustainability goals?
Contact us via the form or alternatively email libby.marshall@glasgow.ac.uk to discuss collaboration opportunities.